Neuronetics Inc (STIM)
1.13
+0.04
(+3.20%)
USD |
NASDAQ |
Nov 05, 11:32
Neuronetics Profit Margin (Quarterly): -59.77% for June 30, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
Date | Value |
---|---|
June 30, 2024 | -59.77% |
March 31, 2024 | -45.20% |
December 31, 2023 | -26.47% |
September 30, 2023 | -52.51% |
June 30, 2023 | -27.83% |
March 31, 2023 | -67.70% |
December 31, 2022 | -45.55% |
September 30, 2022 | -46.12% |
June 30, 2022 | -63.83% |
March 31, 2022 | -76.43% |
December 31, 2021 | -50.83% |
September 30, 2021 | -59.07% |
June 30, 2021 | -52.98% |
March 31, 2021 | -64.14% |
December 31, 2020 | -23.47% |
Date | Value |
---|---|
September 30, 2020 | -27.46% |
June 30, 2020 | -79.71% |
March 31, 2020 | -109.9% |
December 31, 2019 | -43.52% |
September 30, 2019 | -42.92% |
June 30, 2019 | -42.81% |
March 31, 2019 | -59.15% |
December 31, 2018 | -39.29% |
September 30, 2018 | -36.11% |
June 30, 2018 | -56.56% |
March 31, 2018 | -54.15% |
December 31, 2017 | -40.67% |
September 30, 2017 | -35.77% |
June 30, 2017 | -27.82% |
March 31, 2017 | -59.98% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-109.9%
Minimum
Mar 2020
-23.47%
Maximum
Dec 2020
-53.82%
Average
-52.51%
Median
Sep 2023
Profit Margin (Quarterly) Benchmarks
Quest Diagnostics Inc | 9.08% |
Delcath Systems Inc | -176.9% |
Star Equity Holdings Inc | -28.09% |
CytoSorbents Corp | -46.86% |
Progyny Inc | 5.42% |
Profit Margin (Quarterly) Related Metrics
Return on Equity | -98.61% |
Return on Assets | -31.85% |
Return on Invested Capital | -38.96% |
Gross Profit Margin (Quarterly) | 74.04% |
Operating Margin (Quarterly) | -51.71% |
Return on Net Operating Assets | -98.67% |